top of page
Jun 10, 2024
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and...
bottom of page